China Biologic Products Company Profile (NASDAQ:CBPO)

About China Biologic Products

China Biologic Products logoChina Biologic Products, Inc. (China Biologic) is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates in the manufacture and sales of human plasma products segment. It has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across over nine categories. Its principal products are human albumin and immunoglobulin for intravenous injection (IVIG). China Biologic operates its business through approximately two subsidiaries, namely, Shandong Taibang Biological Products Co. Ltd. and Guizhou Taibang Biological Products Co., Ltd. The Company also holds an interest in Xi'an Huitian Blood Products Co., Ltd., a plasma products company. Its products also include Human rabies immunoglobulin, Human tetanus immunoglobulin, Placenta polypeptide, Factor VIII and Human prothrombin complex concentrate.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CBPO
  • CUSIP:
Key Metrics:
  • Previous Close: $122.14
  • 50 Day Moving Average: $119.13
  • 200 Day Moving Average: $116.44
  • 52-Week Range: $84.68 - $144.29
  • Trailing P/E Ratio: 36.27
  • Foreward P/E Ratio: 24.12
  • P/E Growth: 1.59
  • Market Cap: $3.38B
  • Outstanding Shares: 26,892,000
  • Beta: 1.6
Profitability:
  • Net Margins: 29.66%
  • Return on Equity: 19.65%
  • Return on Assets: 16.98%
Debt:
  • Current Ratio: 6.28%
  • Quick Ratio: 4.17%
Additional Links:
Companies Related to China Biologic Products:

Analyst Ratings

Consensus Ratings for China Biologic Products (NASDAQ:CBPO) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $148.67 (18.30% upside)

Analysts' Ratings History for China Biologic Products (NASDAQ:CBPO)
Show:
DateFirmActionRatingPrice TargetDetails
8/5/2016Jefferies GroupBoost Price TargetBuy$136.00 -> $155.00View Rating Details
7/5/2016Credit Suisse Group AGUpgradeNeutral -> OutperformView Rating Details
1/7/2016Deutsche Bank AGBoost Price TargetBuy$149.00 -> $162.00View Rating Details
7/9/2015Bank of America Corp.Initiated CoverageBuy$135.00View Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for China Biologic Products (NASDAQ:CBPO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2016        
8/4/2016Q216$1.16$1.26$87.60 million$91.40 millionViewN/AView Earnings Details
5/4/2016Q116$0.88$0.94$74.00 million$85.60 millionViewN/AView Earnings Details
2/25/2016Q415$0.55$0.74$66.77 million$68.30 millionViewListenView Earnings Details
11/3/2015Q315$0.81$0.82$75.30 million$78.80 millionViewN/AView Earnings Details
8/5/2015Q215$0.87$1.06$71.75 million$79.10 millionViewN/AView Earnings Details
5/6/2015Q1 15$0.84$0.87ViewN/AView Earnings Details
3/4/2015Q4 14$0.51$0.48ViewN/AView Earnings Details
5/6/2014Q114$0.47$0.69$51.40 million$56.27 millionViewN/AView Earnings Details
3/12/2014Q413$0.38$0.35$41.50 million$42.60 millionViewN/AView Earnings Details
11/5/2013Q313$0.42$0.56$47.20 million$53.20 millionViewN/AView Earnings Details
11/8/2012Q312$0.54$41.30 million$53.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for China Biologic Products (NASDAQ:CBPO)
Current Year EPS Consensus Estimate: $4.01 EPS
Next Year EPS Consensus Estimate: $5.21 EPS

Dividends

Dividend History for China Biologic Products (NASDAQ:CBPO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for China Biologic Products (NASDAQ:CBPO)
Insider Ownership Percentage: 2.68%
Institutional Ownership Percentage: 71.71%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2016Ming YangCFOSell21,092$124.32$2,622,157.44View SEC Filing  
8/15/2016Wenfang LiuDirectorSell2,900$124.32$360,528.00View SEC Filing  
8/15/2016Zhijing Cbpo LiuInsiderSell1,968$124.32$244,661.76View SEC Filing  
6/8/2016Wp X Biologics LlcDirectorSell2,775,000$111.00$308,025,000.00View SEC Filing  
5/20/2016Ming YangCFOSell13,908$113.64$1,580,505.12View SEC Filing  
5/20/2016Ming YinVPSell19,618$113.64$2,229,389.52View SEC Filing  
3/11/2016Zhijing Cbpo LiuVPSell282$108.00$30,456.00View SEC Filing  
3/7/2016Wp X Biologics LlcDirectorSell4,257,000$107.00$455,499,000.00View SEC Filing  
12/7/2015Zhijun TongDirectorSell15,000$118.33$1,774,950.00View SEC Filing  
11/4/2015David GaoCEOSell95,991$115.60$11,096,559.60View SEC Filing  
11/2/2015David GaoCEOSell12,891$112.26$1,447,143.66View SEC Filing  
10/29/2015David GaoCEOSell71,118$110.21$7,837,914.78View SEC Filing  
10/26/2015David GaoCEOSell59,542$105.22$6,265,009.24View SEC Filing  
10/20/2015David GaoCEOSell258$105.00$27,090.00View SEC Filing  
10/19/2015David GaoCEOSell200$105.03$21,006.00View SEC Filing  
9/15/2015Ming YangCFOSell9,000$94.56$851,040.00View SEC Filing  
9/15/2015Ming YinVPSell20,508$95.55$1,959,539.40View SEC Filing  
9/14/2015Ming YangCFOSell11,304$97.08$1,097,392.32View SEC Filing  
9/14/2015Wenfang LiuDirectorSell2,717$97.02$263,603.34View SEC Filing  
9/14/2015Zhijing Cbpo LiuVPSell6,786$99.29$673,781.94View SEC Filing  
6/15/2015Wp X Biologics LlcDirectorSell2,645,000$100.28$265,240,600.00View SEC Filing  
11/21/2014Zhijing Cbpo LiuVPSell8,000$68.95$551,600.00View SEC Filing  
11/10/2014Sean ShaoDirectorSell72,500$62.75$4,549,375.00View SEC Filing  
11/10/2014Zhijing Cbpo LiuVPSell7,500$62.75$470,625.00View SEC Filing  
9/15/2014Gang Cbpo YangVPSell2,454$54.00$132,516.00View SEC Filing  
9/15/2014Ming YangCFOSell6,164$54.00$332,856.00View SEC Filing  
9/12/2014Ming YinVPSell3,073$54.00$165,942.00View SEC Filing  
9/12/2013Wenfang LiuDirectorSell2,524$25.00$63,100.00View SEC Filing  
5/14/2013Wp X Biologics LlcDirectorBuy3,112,920$20.00$62,258,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for China Biologic Products (NASDAQ:CBPO)
DateHeadline
News IconStock Chart to Observe: Could China Biologic Products Inc Change Direction After This Inverse Head & Shoulders ... - Chester News (NASDAQ:CBPO)
www.chesterindependent.com - September 27 at 4:02 PM
investornewswire.com logoShares Of China Biologic Products, Inc. (NASDAQ:CBPO) Expected To Hit $162 - Investor Newswire (NASDAQ:CBPO)
www.investornewswire.com - September 26 at 4:19 PM
investornewswire.com logoShares Of China Biologic Products, Inc. (NASDAQ:CBPO) Expected To Hit $162 - Investor Newswire (NASDAQ:CBPO)
www.investornewswire.com - September 26 at 4:19 PM
investorplace.com logo10 Biotechnology Stocks to Buy Now - Investorplace.com (NASDAQ:CBPO)
investorplace.com - September 26 at 4:19 PM
investorplace.com logo10 Biotechnology Stocks to Buy Now - Investorplace.com (NASDAQ:CBPO)
investorplace.com - September 26 at 4:19 PM
News IconWhat is the Street Saying About China Biologic Products, Inc. (NASDAQ:CBPO)? - Frisco Fastball (NASDAQ:CBPO)
friscofastball.com - September 22 at 4:15 PM
News IconChina Biologic Products Earns Outperform Rating from Analysts at Credit Suisse (CBPO) - Petro Global News 24 (NASDAQ:CBPO)
petroglobalnews24.com - September 22 at 4:15 PM
streetinsider.com logoChina Biologic Products (CBPO) Unit Receives China FDA Approval to Begin Human Coagulation Factor IX Trial (NASDAQ:CBPO)
www.streetinsider.com - September 20 at 9:57 AM
biz.yahoo.com logoCHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:CBPO)
biz.yahoo.com - September 20 at 9:57 AM
streetinsider.com logoChina Biologic Products (CBPO) Unit Receives China FDA Approval ... - StreetInsider.com (NASDAQ:CBPO)
www.streetinsider.com - September 19 at 4:54 PM
nasdaq.com logoChina Biologic Gets CFDA Trial Approval For Human Coagulation Factor IX (NASDAQ:CBPO)
www.nasdaq.com - September 19 at 8:51 AM
publicnow.com logoChina Biologic Receives CFDA Clinical Trial Approval for Human Coagulation Factor IX (NASDAQ:CBPO)
www.publicnow.com - September 19 at 8:51 AM
News IconNotable Pattern Reporting: Could China Biologic Products Inc Go Up? The Stock Formed Bullish Inverse Head ... - Chester News (NASDAQ:CBPO)
www.chesterindependent.com - September 17 at 4:00 PM
News IconShares Holding Above Moving Averages: China Biologic Products, Inc. (NASDAQ:CBPO) - Post News (NASDAQ:CBPO)
www.kentuckypostnews.com - September 14 at 4:08 PM
News IconStock Update: Estimates & Target in Focus for China Biologic ... - Frisco Fastball (NASDAQ:CBPO)
friscofastball.com - September 9 at 4:00 PM
capitalcube.com logoChina Biologic Products, Inc. – Value Analysis (NASDAQ:CBPO) : September 8, 2016 (NASDAQ:CBPO)
www.capitalcube.com - September 8 at 3:59 PM
capitalcube.com logoChina Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : September 7, 2016 (NASDAQ:CBPO)
www.capitalcube.com - September 7 at 9:26 AM
capitalcube.com logoETF’s with exposure to China Biologic Products, Inc. : September 6, 2016 (NASDAQ:CBPO)
www.capitalcube.com - September 6 at 4:00 PM
bloomberg.com logoSoros, Harvard Make Opposite Bets on China Plasma Company: Chart (NASDAQ:CBPO)
www.bloomberg.com - September 1 at 12:33 PM
capitalcube.com logoETF’s with exposure to China Biologic Products, Inc. : August 25, 2016 (NASDAQ:CBPO)
www.capitalcube.com - August 25 at 4:08 PM
capitalcube.com logoChina Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : August 24, 2016 (NASDAQ:CBPO)
www.capitalcube.com - August 24 at 12:07 PM
investornewswire.com logoWill China Biologic Products, Inc. (NASDAQ:CBPO) Hit $162 Price Target? - Investor Newswire (NASDAQ:CBPO)
www.investornewswire.com - August 23 at 8:14 AM
nasdaq.com logoChina Biologic Products Breaks Below 200-Day Moving Average - Notable for CBPO - Nasdaq (NASDAQ:CBPO)
www.nasdaq.com - August 18 at 3:22 PM
nasdaq.com logoChina Biologic Products Breaks Below 200-Day Moving Average - Notable for CBPO (NASDAQ:CBPO)
www.nasdaq.com - August 18 at 12:31 PM
biz.yahoo.com logoCHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and (NASDAQ:CBPO)
biz.yahoo.com - August 16 at 10:27 AM
publicnow.com logoChina Biologic Announces Change to Board of Directors (NASDAQ:CBPO)
www.publicnow.com - August 15 at 11:20 AM
fidaily.com logoChina Biologic Products, Inc. (CBPO) Position Decreased by Warburg Pincus LLC - Finance Daily (NASDAQ:CBPO)
www.fidaily.com - August 14 at 8:51 AM
finance.yahoo.com logoCHINA BIOLOGIC PRODUCTS, INC. Financials (NASDAQ:CBPO)
finance.yahoo.com - August 12 at 4:06 PM
thestreet.com logoChinese Plasma Maker China Biologic a Solid Addition for a Portfolio (NASDAQ:CBPO)
www.thestreet.com - August 11 at 12:23 PM
capitalcube.com logoChina Biologic Products, Inc.: Leads amongst peers with strong fundamentals (NASDAQ:CBPO)
www.capitalcube.com - August 8 at 9:30 PM
capitalcube.com logoChina Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016 (NASDAQ:CBPO)
www.capitalcube.com - August 8 at 4:09 PM
investornewswire.com logoStrong Sell Calls For China Biologic Products, Inc. (NASDAQ:CBPO) At 0 - Investor Newswire (NASDAQ:CBPO)
www.investornewswire.com - August 8 at 8:56 AM
finance.yahoo.com logoEdited Transcript of CBPO earnings conference call or presentation 5-Aug-16 11:30am GMT (NASDAQ:CBPO)
finance.yahoo.com - August 5 at 9:30 PM
rttnews.com logoChina Biologic Products Inc. Profit Climbs 23% In Q2 - RTT News (NASDAQ:CBPO)
www.rttnews.com - August 5 at 4:09 PM
twst.com logoChina Biologic Products Inc.: China Biologic Reports Financial Results for the Second Quarter of 2016 (NASDAQ:CBPO)
www.twst.com - August 5 at 12:30 PM
sg.finance.yahoo.com logoChina Biologic Products posts 2Q profit (NASDAQ:CBPO)
sg.finance.yahoo.com - August 5 at 12:30 PM
nasdaq.com logoChina Biologic Products Inc. Profit Climbs 23% In Q2 (NASDAQ:CBPO)
www.nasdaq.com - August 4 at 9:49 PM
finance.yahoo.com logo5:09 pm China Biologic Products beats by $0.08, beats on revs (NASDAQ:CBPO)
finance.yahoo.com - August 4 at 9:49 PM
publicnow.com logoChina Biologic Reports Financial Results for the Second Quarter of 2016 (NASDAQ:CBPO)
www.publicnow.com - August 4 at 9:49 PM
biz.yahoo.com logoCHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations a (NASDAQ:CBPO)
biz.yahoo.com - August 4 at 9:49 PM
biz.yahoo.com logoQ2 2016 China Biologic Products Inc Earnings Release - After Market Close (NASDAQ:CBPO)
biz.yahoo.com - August 4 at 12:44 PM
News IconEquity Roundup: Stock Performance Focus on China Biologic Products, Inc. (NASDAQ:CBPO) - Press Telegraph (NASDAQ:CBPO)
presstelegraph.com - July 23 at 8:23 AM
publicnow.com logoChina Biologic Products to Report Second Quarter 2016 Financial Results (NASDAQ:CBPO)
www.publicnow.com - July 22 at 8:58 AM
News IconChina Biologic Products, Inc. (NASDAQ:CBPO): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:CBPO)
www.engelwooddaily.com - July 20 at 11:23 PM
News IconShares Turning Downward: China Biologic Products, Inc. (NASDAQ:CBPO) - TGP (NASDAQ:CBPO)
telanaganapress.com - July 20 at 11:23 PM
News IconHow Analysts Feel About China Biologic Products Inc (NASDAQ:CBPO)? - Consumer Eagle (NASDAQ:CBPO)
www.consumereagle.com - July 20 at 12:09 PM
News IconLong Term Value Play: China Biologic Products, Inc. (NASDAQ:CBPO) - TGP (NASDAQ:CBPO)
telanaganapress.com - July 19 at 9:29 PM
tradecalls.org logoCutler Group Lp buys $6963821 stake in China Biologic Products Inc (CBPO) - Trade Calls (NASDAQ:CBPO)
www.tradecalls.org - July 19 at 4:10 PM
capitalcube.com logoChina Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : July 18, 2016 (NASDAQ:CBPO)
www.capitalcube.com - July 18 at 8:21 AM
ftsenews.co.uk logoNew Broker Ratings For China Biologic Products, Inc. (NASDAQ:CBPO) - FTSE News (NASDAQ:CBPO)
www.ftsenews.co.uk - July 15 at 7:31 PM

Social

China Biologic Products (NASDAQ:CBPO) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff